首页 正文

Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma

{{output}}
Head and neck squamous cell carcinoma (HNSCC) has an estimated annual global death rate of approximately 300,000. Despite advances in surgical techniques, the advent of efficient radiation delivery methods, and the introduction of newer chemotherapeutic agents... ...